Cytek Biosciences, Inc.CTKBNASDAQ
Loading
Debt to Assets Over TimeElevated
Percentile Rank100
3Y CAGR+27.1%
5Y CAGR+41.5%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
+27.1%/yr
Annual compound
5Y CAGR
+41.5%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
5.7x
Strong expansion
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.07 | +110.0% |
| 2024 | 0.03 | +19.2% |
| 2023 | 0.03 | -17.9% |
| 2022 | 0.03 | - |
| 2021 | 0.00 | -100.0% |
| 2020 | 0.01 | - |
| 2019 | 0.00 | - |